Genta, Inc (fka GNTAQ)

[BLULLISH]

DON'T TAKE THIS PERSONAL, YOU DON'T SEEM TO UNDERSTAND HOW UP AND COMMING BIOPHARMACEUTICALS OR BIOTECHS TRADE AND HOW THIER BALANCE SHEETS TEND TO LOOK LIKE IN THIER EARLY STAGES AND LATE STAGES. THESE COMPANIES ALMOST ALWAYS ARE IN THE RED. TRADERS ARE USUALLY WILLING TO PAY MUCH,MUCH MORE THAN THE TRUE VALUE, ESPECIALLY IF THE DRUG HAS HUGE POTENTIAL, LIKE TESETAXEL.

YOU DON'T HAVE TO TAKE MY WORD FOR IT. ALL YOU HAVE TO DO GO TAKE A LOOK AT 10 TO 20 BIOTECHS BALANCE SHEET.

THE PREDICTION OF 0.02 TO 0.05 A SHARE IS VERY REALISTIC.

WHY DO YOU THINK STANDARD AND POOR'S IS COVERING THIS STOCK?

STANDARD AND POOR'S MUST SEE SOMETHING IN THE COMPANY.